A team of researchers has come up with a new approach to help lower blood sugar levels in diabetics.
Some treatments for type 2 diabetes make the body more sensitive to insulin, the hormone that lowers blood sugar, but Washington University School of Medicine study suggested a different strategy: slowing the production of glucose in the liver.
Working in mice, the researchers showed they could reduce glucose production in the liver and lower blood sugar levels.
They did so by shutting down a liver protein involved in making glucose, an approach that may work in patients with type 2 diabetes.
Principal investigator Brian N. Finck said that they think this strategy could lead to more effective drugs for type 2 diabetes.
Finck added that a drug that shuts down glucose production has the potential to help millions of people affected by the most common form of diabetes.
In addition to diabetes, the researchers also think that interfering with pyruvate transport may help patients with non-alcoholic fatty liver disease, a condition common in people with obesity.
The research is published online in Cell Metabolism.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
